-
2008
27 November 2008: Announcement no. 3, 2008: Zealand Pharma and Helsinn Healthcare S...
-
Product Pipeline
Zealand's Pipeline comprises 1 compound in phase III, 1 compound in phase II, 2 c...
Thomas Tscherning, Board member
Board member since 2008. Mister Tscherning holds a MD from Copenhagen University, an MBA and a diploma in Healthcare Management from Copenhagen Business School, a diploma in Pharmaceutical Medicine from Karolinska Institute, and he is a Chartered Director from Institute of Directors (UK).Thomas Tscherning joined BankInvest Biomedical Venture in 1997. Tomas Tschering is responsible for a number of BI Biomedical Venture's portfolio companies and serves currently as Chairman of Zymenex A/S and as a Board member of F2G, Pronostics. Prior to BankInvest Mister Tscherning worked as a licensed medical doctor at medical, surgical and emergency departments and is a licensed investigator on both pre-clinical and clinical studies.
Tip a friend
Fill in the form below to tip a friend about this page.
Subscribe
When this page is updated you will be updated by e-mail.